Table 4.

Reports of resource utilization in non-bleeding patients with IMC

Category	Count	%
Extended LOS	23	92.0%
Vit K	9	36.0%
FFP	8	32.0%
IVIG	5	20.0%
Plasmapheresis	5	20.0%
Steroids	4	16.0%
PLT	1	4.0%
Chemotherapy	0	0.0%
RBC	0	0.0%

LOS – Length of stay; FFP – fresh frozen plasma; Vit K – vitamin K; IVIG – intravenous immune globulin; PLT – platelets; RBC – red blood cells

Interventions among the 25 non-bleeding patients for whom case reports contained documentation of managing immune-mediated coagulopathy [3-5,8,9,11,12,14,15,18,21,22,24-26,28-31,35].